135 related articles for article (PubMed ID: 9512942)
1. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
[TBL] [Abstract][Full Text] [Related]
2. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
[TBL] [Abstract][Full Text] [Related]
3. The relationship of diastereomer hydrolysis kinetics to shelf-life predictions for cefuroxime axetil.
Nguyen NA
Pharm Res; 1991 Jul; 8(7):893-8. PubMed ID: 1924141
[TBL] [Abstract][Full Text] [Related]
4. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
[TBL] [Abstract][Full Text] [Related]
5. Photoisomerization kinetics of cefuroxime axetil and related compounds.
Fabre H; Ibork H; Lerner DA
J Pharm Sci; 1994 Apr; 83(4):553-8. PubMed ID: 8046613
[TBL] [Abstract][Full Text] [Related]
6. Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
Dantzig AH; Duckworth DC; Tabas LB
Biochim Biophys Acta; 1994 Apr; 1191(1):7-13. PubMed ID: 8155686
[TBL] [Abstract][Full Text] [Related]
7. Esterase activity toward the diastereomers of cefuroxime axetil in the rat and dog.
Mosher GL; McBee J; Shaw DB
Pharm Res; 1992 May; 9(5):687-9. PubMed ID: 1608904
[No Abstract] [Full Text] [Related]
8. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
Lang CC; Moreland TA; Davey PG
J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
[TBL] [Abstract][Full Text] [Related]
9. Penetration of oral cefuroxime axetil into the human aqueous humor.
Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
[TBL] [Abstract][Full Text] [Related]
10. Esters of cephalosporins. Part II. Differences in the properties of various forms of the 1-acetoxyethyl ester of cefuroxime.
Oszczapowicz I; Małafiej E; Szelachowska M; Horoszewicz-Małafiej A; Kuklewicz C; Sierańska E; Denys A; Niedworok J
Acta Pol Pharm; 1995; 52(5):397-401. PubMed ID: 8960273
[TBL] [Abstract][Full Text] [Related]
11. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Perry CM; Brogden RN
Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
[TBL] [Abstract][Full Text] [Related]
12. Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability.
Stoeckel K; Hofheinz W; Laneury JP; Duchene P; Shedlofsky S; Blouin RA
Antimicrob Agents Chemother; 1998 Oct; 42(10):2602-6. PubMed ID: 9756762
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of stability of cefuroxime axetil in solid state.
Zajac M; Jelińska A; Dobrowolski L; Oszczapowicz I
J Pharm Biomed Anal; 2003 Aug; 32(6):1181-7. PubMed ID: 12907262
[TBL] [Abstract][Full Text] [Related]
14. Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.
Vasu S; Adithan C; Shashindran CH; Asad M; Koumaravelou K; Topno I
Indian J Med Res; 2000 Sep; 112():104-8. PubMed ID: 11094856
[TBL] [Abstract][Full Text] [Related]
15. Experimental Determination and Theoretical Calculation of the Eutectic Composition of Cefuroxime Axetil Diastereomers.
Dalal N; Buckner IS; Wildfong PLD
AAPS PharmSciTech; 2017 Oct; 18(7):2570-2578. PubMed ID: 28229357
[TBL] [Abstract][Full Text] [Related]
16. Esters of cephalosporins. Part III. Separation and properties of the R and S isomers of the 1-acetoxyethyl ester of cefuroxime.
Oszczapowicz I; Małafiej E; Horoszewicz-Małafiej A; Szelachowska M; Kuklewicz C; Sierańska E
Acta Pol Pharm; 1995; 52(6):471-6. PubMed ID: 8960265
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of cefuroxime axetil formulations.
Donn KH; James NC; Powell JR
J Pharm Sci; 1994 Jun; 83(6):842-4. PubMed ID: 9120818
[TBL] [Abstract][Full Text] [Related]
18. Stability of cefuroxime axetil in suspensions.
Pramar Y; Das Gupta V; Bethea C; Zerai T
J Clin Pharm Ther; 1991 Oct; 16(5):341-4. PubMed ID: 1752913
[TBL] [Abstract][Full Text] [Related]
19. Effect of dose and food on the bioavailability of cefuroxime axetil.
Finn A; Straughn A; Meyer M; Chubb J
Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
[TBL] [Abstract][Full Text] [Related]
20. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
Scott LJ; Ormrod D; Goa KL
Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
